If you’re wealthy, you’ll be able to afford help in your home or care in an assisted living facility or a nursing home. If you’re poor, you can turn to Medicaid for nursing homes or aides at home.
Kyverna Therapeutics files for IPO as autoimmune CAR-T space heats up
Kyverna Therapeutics, a clinical-stage biotech examining CAR-T cell therapy’s potential to treat autoimmune diseases, has filed for an initial public offering. The California biotech plans